|Expense Ratio (net)||1.53%|
|Last Cap Gain||0.00|
|Morningstar Risk Rating||N/A|
|Beta (5Y Monthly)||N/A|
|5y Average Return||N/A|
|Average for Category||N/A|
|Inception Date||Aug. 21, 2018|
BMO Capital Markets, the investment & corporate banking arm of BMO Financial Group (NYSE: BMO) (TSX: BMO), today announced that it has hired Evan Seigerman as a Managing Director and Senior Equity Research Analyst covering the biotechnology and pharmaceutical industries.
BMO Investments Inc. (the "Manager"), the manager of the BMO Mutual Funds, confirmed that the previously announced merger of BMO Floating Rate Income Fund into BMO U.S. High Yield Bond Fund will proceed since securityholder approval was obtained at a special meeting held on June 18, 2021 and securities regulatory approval has also been received for this merger.
BMO Asset Management Inc. today announced the June 2021 cash distributions and reinvested distributions for BMO Exchange Traded Funds (BMO ETFs) and ETF Series of the BMO Mutual Funds (ETF Series) that distribute monthly or quarterly. Unitholders of record of the BMO ETFs at the close of business on June 29, 2021 will receive cash or reinvested distributions payable on July 6, 2021.